Form D · Biotechnology

SEMBA BIOSCIENCES INC

Madison, WI · CIK 0001458718

Offering snapshot reported Dec 12, 2018 · SEC filing

Reported sold
$3M
Offering amount: $3M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 1, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 12, 2018Initial$3,000,000No comparison1SEC filing
Jan 5, 2015Initial$511,175No comparison13SEC filing
Dec 22, 2010Amendment$875,000$775,000vs Sep 21, 20109SEC filing
Sep 21, 2010Initial$100,000No comparison1SEC filing
May 11, 2010Initial$120,000No comparison10SEC filing
Mar 9, 2009PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-327768

Source: Form D, filed Dec 12, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joerg Baier Director
Andrew De Marco Director
Stanley Gembicki Director
Steve Gordon Director
John F. Hardin Director
Lisa A Johnson Executive
Kenneth U. Johnson Director
Robert Mierendorf Executive
Asha Oroskar Promoter
Anil Oroskar Promoter
Stelios Papadopoulos Director
John Scheller Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
601 Science Dr. Ste. 110
Madison, WI, 53711